bpc 157 for cancer FDA Committee Votes to Ease Restrictions on Six Peptides bpc 157 angiogenesis cancer Peptide

Peer-reviewed studies relevant to 5-Amino-1MQ are listed in the Citations tab on this product page

These include: Pain, redness, or swelling at the injection site Bruising or hardening of tissue (induration) Itching or warmth around the injection area Temporary discolouration of the skin These localised reactions typically resolve within 2472 hours

Two practical points follow

TUEs are granted for approved pharmaceuticals where the medical need is documented and no permitted alternative exists

GHK-Cu has genuine topical skincare evidence and some anti-inflammatory activity, but injectable use is unapproved and research-grade